ACM
REPL icon

AlphaCrest Capital Management’s Replimune Group REPL Stock Holding History

AlphaCrest Capital Management’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-11,000
Closed -$423K – 1358
2021
Q2 		$423K Buy
+11,000
New +$376K 0.02% 1010

Other funds holding REPL

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

AlphaCrest Capital Management's REPL Position: Q3 2021 in Review

AlphaCrest Capital Management sold out of Replimune Group (REPL) in Q3 2021, closing a stake of 11,000 shares — an estimated $423K sold.

AlphaCrest Capital Management first reported a position in REPL in Q2 2021 and held it in 1 quarter. The position peaked at $423K in Q2 2021. 101 funds tracked by Wall St. Rank hold REPL as of Q3 2021.

  • AlphaCrest Capital Management reported no remaining Replimune Group position as of Q3 2021 after selling out during the quarter.
  • AlphaCrest Capital Management sold 11,000 Replimune Group shares in Q3 2021, an estimated $423K.
  • AlphaCrest Capital Management first reported a position in Replimune Group in Q2 2021 and held it in 1 quarter.
  • AlphaCrest Capital Management's Replimune Group position peaked at $423K in Q2 2021.
  • 101 funds tracked by Wall St. Rank held Replimune Group as of Q3 2021.

Based on AlphaCrest Capital Management's 13F filing for Q3 2021, filed 10 Nov 2021.